Submit accurate and timely expense reports, maintain account records and submit timely and thorough account and territory reports
To lead by example and conduct all activities within the letter and spirit of the Innovative Medicines Canada code of ethical practices, in addition to all company policies and procedures
Account Management & Ways of Working
Support the development of Key Opinion Leaders from target accounts
Develop strong relationships by understanding each customer’s needs, goals and competitive product standing
Lead the production, documentation and implementation of detailed account level business plans, aligned with regional and national brand objectives
Drive account focused activity that is led by local needs and priorities and aligns with the brand strategy for VYVGART
Foster true cross-functional collaboration focused on delivering commercial success
Provide key account-level insights into brand planning to ensure that the VYVGART strategy and tactics are fit for purpose
Develop expertise in neurology/rare disease as well as detailed account level knowledge
Coordinate all argenx Canada account level interactions
Maintain a high degree of competence in the areas of product knowledge, disease state knowledge, and industry knowledge impacted by argenx products
Business Planning and Execution
Development of a comprehensive, territory specific business plan which includes strategies and tactics aimed at achieving annual sales goals set by management to rigorously review and ensure all account level activities align with the brand strategy, reviewing documentation in accordance with the relevant governance processes
To lead the account team to deliver focused account plans to support and achieve sales targets within the given timeframe
To ensure that all knowledge management and CRM systems are maintained in accordance with argenx standards and operating procedures
Ensure expenditure is within agreed budget
Skills:
Essential
Highly developed selling skills, commercial acumen and business insights
Exceptional communication skills, with a demonstrated ability to adapt to different customer types and circumstances
High level of influencing and negotiation skills
Consistent successful sales track record (including specialty/hospital experience)
Significant key account management experience and capabilities
Previous evidence of successful working in a cross-functional team
Ability to translate business insights into commercial action plan
Ability to demonstrate strong commercial focus and business acumen
Ability to understand and communicate high level scientific data
Sound understanding of the IMC code and implications for field representatives
Desirable
Proven working knowledge, experience and customer relationships within territory
Prior market access experience – field or head-office based
Experience working in neurology or rare diseases
Personal Skills
You have a professional presence, self-confident and self-driven, with a positive attitude
You are a connector, building relationships and partnering inside and outside the company in order to achieve the individual and team goals
You excel in a fast-paced, results-driven and highly accountable environment
You are pragmatic, creative and innovative and lead while \"rolling up your sleeves\" to get it done
Sees the big picture (enterprise thinking) with the analytical ability to understand and assess the detail
Team focused, with a proven ability to work within an account management framework
Education and Qualifications:
University degree in scientific or business-related subject or equivalent qualification
Minimum 8-10 years of successful field experience in the biopharmaceutical industry
2+ years of institutional, specialty or rare disease sales experience
Start up or launch experience preferred
At least 2 consecutive years of documented sales success
Strong work ethic
Maintain a safe driving record
Job Dimensions:
Field based (with attendance at head office when required, generally 1-2 days per quarter)
Travel 25-50% and coverage of large geographies including multiple provinces
Overnight, multi-night and/or weekend travel may be required to accomplish desired objectives
Bilingual (English/French)
Accountable for territory performance and expenditure
#LI-Hybrid
","datePosted":"2025-04-09T19:58","employmentType":"FULL_TIME","jobLocation":[{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Alberta, Canada","addressRegion":null,"addressCountry":"Canada"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"British Columbia, Canada","addressRegion":null,"addressCountry":"Canada"}},{"@type":"Place","address":{"@type":"PostalAddress","addressLocality":"Saskatchewan, Canada","addressRegion":null,"addressCountry":"Canada"}}],"directApply":false,"hiringOrganization":{"@type":"Organization","name":"argenx","sameAs":"https://argenx.com/","logo":"https://storage.googleapis.com/simplify-imgs/companies/af281c93-f6e8-410a-b0e4-5ef4f1fbf2dc/logo.png"},"identifier":{"@type":"PropertyValue","name":"argenx","value":"af281c93-f6e8-410a-b0e4-5ef4f1fbf2dc"}}Full-Time
Biotechnology for autoimmune diseases and cancer
No salary listed
Senior, Expert
Alberta, Canada + 2 more
More locations: British Columbia, Canada | Saskatchewan, Canada
Field based with attendance at head office when required, generally 1-2 days per quarter. Travel 25-50% and coverage of large geographies including multiple provinces.
Upload your resume to see how it matches 9 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
argenx develops treatments for severe autoimmune diseases and cancer through biotechnology. The company focuses on creating therapeutic antibodies, which are proteins designed to target specific diseases. One of their main products, cusatuzumab, is being developed with Janssen R&D to treat blood cancers like leukemia. What sets argenx apart from its competitors is its strong emphasis on collaboration with academic institutions and industry partners to turn scientific research into effective therapies. The company's goal is to advance immunology solutions that can significantly improve patient outcomes in challenging medical conditions.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Ghent, Belgium
Founded
2008
Help us improve and share your feedback! Did you find this helpful?
Hybrid Work Options
argenx, a global immunology company focused on improving lives of people with severe autoimmune diseases, has announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the TD Cowen 45th Annual Healthcare Conference.
Alongside financing, first patients dosed in OV-AML-1231, a Phase 2 randomized controlled trial of cusatuzumab in newly diagnosed AML
Steritas LLC, a company focused on improving care for patients treated with steroids, has partnered with global immunology company Argenx.
$398 million in first quarter global net product sales. FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024. On track to submit filing for pre-filled syringe (PFS) in second quarter 2024
Amsterdam, the Netherlands – argenx (Euronext Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 9, 2024 at 2:30 PM CET (8:30 AM ET) to discuss its first quarter 2024 financial results and provide a business update.A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.Dial-in numbers:Belgium 32 800 50 201. France 33 800 943355. Netherlands 31 20 795 1090